{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:53:14Z","timestamp":1780563194506,"version":"3.54.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Sexual Trans Dis"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">Neisseria gonorrhoeae<\/jats:italic> (Ng) is a public health priority because of the rapid evolution of antimicrobial resistance, the emergence of antibiotic resistance, and the absence of a vaccine against Ng. The aim of this study was to investigate trends in the minimum inhibitory concentration and resistance (R) or reduced susceptibility (DS) of Ng cases to ceftriaxone (CRO), azithromycin (AZM), tetracycline (TET), benzylpenicillin (PenG), and ciprofloxacin (CIP) during a 10-year period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective analysis on an open cohort of Ng cases diagnosed on rectal, urethral, and pharyngeal samples at San Raffaele Scientific Institute, between September 2012 and February 2023. Minimum inhibitory concentrations of antibiotics were determined by gradient-test strips. Bivariate linear regression models were applied on logarithmic minimum inhibitory concentrations values; Cochran-Armitage test was used to determine a linear trend in the proportions of resistant strains.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 436 Ng isolates from 352 individuals were analyzed. Minimum inhibitory concentrations of CRO and PenG reduced over time (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.030), AZM increased (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001), and CIP and TET did not change (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.473, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.272). The percentages of resistant strains were as follows: PenG, 89.9%; TET, 90.8%; CIP, 48.2%; AZM, and 4.4%. CRO-DS strains were 8.7%, and only 1 case of CRO-R was identified. The proportion of resistant strains increased over time for AZM (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007), TET (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001), and CIP (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), whereas it decreased for PenG (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and CRO-DS\/R strains (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Ng strains showed high susceptibility to CRO, although we identified cases of DS\/R and observed high levels of susceptibility to AZM. Overall, the recommended primary regimen for Ng treatment was confirmed to be effective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/olq.0000000000001981","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T09:00:34Z","timestamp":1713776434000},"page":"540-544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6246-132X","authenticated-orcid":false,"given":"Maria Francesca","family":"Lucente","sequence":"first","affiliation":[{"name":"Vita-Salute San Raffaele University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Roberto","family":"Raccagni","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galli","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lolatto","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ranzenigo","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Ponta","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Monardo","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Gona","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Burioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carletti","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Nozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"Suppl 4","key":"bib2-20250816","doi-asserted-by":"crossref","first-page":"iv63","DOI":"10.1136\/sextrans-2013-051225","article-title":"Vaccine research for gonococcal infections: Where are we?","volume":"89","year":"2013","journal-title":"Sex Transm Infect"},{"key":"bib4-20250816","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3389\/fimmu.2018.03044","article-title":"Macrophage\u2013Neisseria gonorrhoeae interactions: A better understanding of pathogen mechanisms of immunomodulation","volume":"9","year":"2018","journal-title":"Front Immunol"},{"key":"bib6-20250816","first-page":"2100917","article-title":"Surveillance systems to monitor antimicrobial resistance in Neisseria gonorrhoeae: A global, systematic review, 1 January 2012 to 27 September 2020","volume":"27","year":"2022","journal-title":"Euro Surveill"},{"key":"bib7-20250816","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: A retrospective observational study","volume":"2","year":"2021","journal-title":"Lancet Microbe"},{"key":"bib9-20250816","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s10096-020-03907-7","article-title":"Fifteen years of a nationwide culture collection of Neisseria gonorrhoeae antimicrobial resistance in Portugal","volume":"39","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"bib10-20250816","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10096-023-04601-0","article-title":"Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016\u20132019","volume":"42","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"bib11-20250816","first-page":"2200057","article-title":"Antimicrobial-resistant gonorrhoea: The national public health response, England, 2013 to 2020","volume":"27","year":"2022","journal-title":"Euro Surveill"},{"key":"bib12-20250816","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/mdr.2021.0483","article-title":"Seven years of culture collection of Neisseria gonorrhoeae: Antimicrobial resistance and molecular epidemiology","volume":"29","year":"2023","journal-title":"Microb Drug Resist"},{"key":"bib13-20250816","doi-asserted-by":"crossref","first-page":"e0189484","DOI":"10.1371\/journal.pone.0189484","article-title":"Time trend analysis (2009\u20132016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"bib14-20250816","doi-asserted-by":"crossref","first-page":"e1002344","DOI":"10.1371\/journal.pmed.1002344","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action","volume":"14","year":"2017","journal-title":"PLoS Med"},{"key":"bib17-20250816","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"bib18-20250816","first-page":"956462420949126","article-title":"European guideline for the diagnosis and treatment of gonorrhoea in adults","volume":"2020","year":"2020","journal-title":"Int J STD AIDS"},{"key":"bib19-20250816","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1473-3099(18)30122-1","article-title":"Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: An observational study","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"bib20-20250816","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dkaa536","article-title":"Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016\u201318","volume":"76","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"bib21-20250816","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/cid\/ciab132","article-title":"Sustained transmission of Neisseria gonorrhoeae with high-level resistance to azithromycin, in Indianapolis, Indiana, 2017\u20132018","volume":"73","year":"2021","journal-title":"Clin Infect Dis"},{"key":"bib22-20250816","first-page":"2100616","article-title":"Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021","volume":"26","year":"2021","journal-title":"Euro Surveill"},{"key":"bib23-20250816","first-page":"1700565","article-title":"Trends and determinants of antimicrobial susceptibility of Neisseria gonorrhoeae in the Netherlands, 2007 to 2015","volume":"23","year":"2018","journal-title":"Euro Surveill"},{"key":"bib24-20250816","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s12879-018-3528-4","article-title":"Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016","volume":"18","year":"2018","journal-title":"BMC Infect Dis"},{"key":"bib25-20250816","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: Past, evolution, and future","volume":"27","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"bib26-20250816","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: An open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"bib27-20250816","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/S1473-3099(23)00359-6","article-title":"Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis","volume":"23","year":"2023","journal-title":"Lancet Infect Dis"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0000000000001981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T16:02:47Z","timestamp":1755360167000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0000000000001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0000000000001981","relation":{},"ISSN":["1537-4521","0148-5717"],"issn-type":[{"value":"1537-4521","type":"electronic"},{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}